Please note, this OEL/ADE monograph also applies to magnesium acetate (CAS RN 142-72-3), magnesium acetate tetrahydrate (CAS RN 16674-78-5), magnesium aspartate (CAS RN 18962-61-3), magnesium aspartate dihydrate (CAS RN 215533-00-9), magnesium carbonate (CAS RN 546-93-0), magnesium carbonate hydrate (CAS RN 17968-26-2), magnesium carbonate trihydrate (CAS RN 5145-46-0), magnesium chloride (CAS RN 14989-29-8), magnesium chloride (CAS RN 7786-30-3), magnesium chloride monohydrate (CAS RN 22756-14-5), magnesium chloride tetrahydrate (CAS RN 22695-80-3), magnesium chloride hexahydrate (CAS RN 7791-18-6), magnesium citrate (CAS RN 3344-18-1), magnesium citrate dibasic (CAS RN 144-23-0), magnesium citrate pentahydrate (CAS RN 6150-80-7), magnesium gluceptate (CAS RN 74347-32-3), magnesium glucoheptonate (CAS RN 68475-44-5), magnesium gluconate (CAS RN 59625-89-7), magnesium gluconate anhydrous (CAS RN 3632-91-5), magnesium hydroxide (CAS RN 1309-42-8), magnesium lactate (CAS RN 18917-93-6), magnesium lactate dihydrate (CAS RN 179308-96-4), magnesium lactate trihydrate (CAS RN 6150-84-1), magnesium phosphate (CAS RN 10043-83-1), magnesium phosphate anhydrous (CAS RN 7757-87-1), magnesium phosphate dibasic (CAS RN 7757-86-0), magnesium phosphate dibasic trihydrate (CAS RN 7782-75-4), magnesium sulfate anhydrous(CAS RN 7487-88-9), magnesium sulfate monohydrate (CAS RN 14168-73-1), magnesium sulfate heptahydrate (CAS RN 10034-99-8), magnesium pidolate (CAS RN 5819-47-6), magnesium glycinate (CAS RN 14783-68-7), and magnesium alpha-glycerophosphate (CAS RN 927-20-8) Magnesium (Mg) is an alkaline metal, the major cation of the body. As a medication, it is used for many purposes, mostly in the form of salts. Magnesium salts are used as antacids, laxatives, in the treatment of eclampsia, to treat cardiac dysrhythmias, to treat magnesium deficiency, and in urological irrigation solutions used for dissolution of urinary calculi.
Affygility Solutions has an occupational exposure limit (OEL) and control band assignment for this active pharmaceutical ingredient (API). This monograph also contains the acceptable daily exposure (ADE) value.
OEL Fastrac monographs are a cost-effective and convenient way to meet the requirements for PDEs (ADEs) contained in the EMA Guideline on setting health based exposure limits for use in risk identification in the manufacture of different medicinal products in shared facilities (EMA/CHMP/CVMP/SWP/169430/2012), as well as PIC/S and ANVISA requirements, and to obtain the following information:
To order an OEL/ADE monograph for Magnesium, just click the ADD TO CART button.
If you're wondering about HBEL, we have something for you.
Not the compound you were looking for? You can search the OEL Fastrac catalog to find more available compounds.
Affygility Solutions’ OEL Fastrac service is an user-friendly system that enables us to make confident decisions and focus on moving the compound safely through our facility. We can quickly access the database to determine if a new drug is within the OEL Fastrac library, and if so, immediately download a detailed OEL banding report. The OEL Fastrac system has been a helpful tool in our overall EH&S program.